These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation. Kuehlwein JM, Borsche M, Korir PJ, Risch F, Mueller AK, Hübner MP, Hildner K, Hoerauf A, Dunay IR, Schumak B. Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339 [Abstract] [Full Text] [Related]
3. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A. Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776 [Abstract] [Full Text] [Related]
4. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development. Palomo J, Reverchon F, Piotet J, Besnard AG, Couturier-Maillard A, Maillet I, Tefit M, Erard F, Mazier D, Ryffel B, Quesniaux VF. Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948 [Abstract] [Full Text] [Related]
5. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. Palomo J, Fauconnier M, Coquard L, Gilles M, Meme S, Szeremeta F, Fick L, Franetich JF, Jacobs M, Togbe D, Beloeil JC, Mazier D, Ryffel B, Quesniaux VF. Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878 [Abstract] [Full Text] [Related]
6. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice. Lv Y, Wu S, Nie Q, Liu S, Xu W, Chen G, Du Y, Chen J. Int Immunopharmacol; 2024 May 10; 132():111982. PubMed ID: 38569430 [Abstract] [Full Text] [Related]
7. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria. Nyariki JN, Kimani NM, Kibet PS, Kinuthia GK, Isaac AO. Mol Biochem Parasitol; 2023 Sep 10; 255():111579. PubMed ID: 37385350 [Abstract] [Full Text] [Related]
9. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Keswani T, Bhattacharyya A. Exp Parasitol; 2014 Jun 10; 141():82-92. PubMed ID: 24675415 [Abstract] [Full Text] [Related]
13. L-arginine exacerbates experimental cerebral malaria by enhancing pro-inflammatory responses. Xu H, Feng Y, Chen G, Zhu X, Pang W, Du Y, Wang Q, Qi Z, Cao Y. Tohoku J Exp Med; 2015 May 10; 236(1):21-31. PubMed ID: 25925198 [Abstract] [Full Text] [Related]
14. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of P. berghei ANKA Infected C57BL/6 Mice. Mukherjee S, Ray G, Saha B, Kar SK. Front Immunol; 2021 May 10; 12():819469. PubMed ID: 35095923 [Abstract] [Full Text] [Related]
15. CD8+ and CD4+ T Cells Infiltrate into the Brain during Plasmodium berghei ANKA Infection and Form Long-Term Resident Memory. Ghazanfari N, Gregory JL, Devi S, Fernandez-Ruiz D, Beattie L, Mueller SN, Heath WR. J Immunol; 2021 Sep 15; 207(6):1578-1590. PubMed ID: 34400523 [Abstract] [Full Text] [Related]
19. Phenylhydrazine administration accelerates the development of experimental cerebral malaria. Zhu X, Liu J, Feng Y, Pang W, Qi Z, Jiang Y, Shang H, Cao Y. Exp Parasitol; 2015 Sep 15; 156():1-11. PubMed ID: 26005191 [Abstract] [Full Text] [Related]
20. Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response. He X, Yan J, Zhu X, Wang Q, Pang W, Qi Z, Wang M, Luo E, Parker DM, Cantorna MT, Cui L, Cao Y. J Immunol; 2014 Aug 01; 193(3):1314-23. PubMed ID: 24965778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]